Journal of Lipid Research, Vol 32, 147-155, Copyright © 1991 by Lipid Research, Inc.

ARTICLES

Uptake, metabolism, and cytotoxicity of isomeric cholesterol-5,6- epoxides in rabbit aortic endothelial cells

A Sevanian, J Berliner and H Peterson
Institute for Toxicology, University of Southern California, Los Angeles 90033.

The isomeric cholesterol-5,6-epoxides represent two common cholesterol autoxidation products and along with their principal metabolic product, 3 beta,5 alpha,6 beta-cholestane triol, are purportedly angiotoxic. The uptake and cytotoxic action of these compounds was examined in cultured rabbit aortic endothelial cells emphasizing mechanisms of uptake and metabolic fate. The isomeric cholesterol epoxides are incorporated with equal facility and in a dose-dependent manner. The pattern of uptake, which is markedly influenced by media serum concentration and by temperature, suggests that these compounds are partly incorporated through association with serum lipoproteins. After incorporation, both epoxide isomers are rapidly converted to cholestane triol which readily exits the cells. Cholestane triol is further metabolized to an ester- type product representing up to 10% of the added cholesterol epoxides by 24 h of incubation. The order of cytotoxic potency of these cholesterol oxides is: cholestane triol greater than cholesterol-beta- epoxide greater than cholesterol-alpha-epoxide, with LD50 concentrations ranging from 23 to greater than 150 microM in confluent cells. Cholestane triol and cholesterol-beta-epoxide are twice as cytotoxic to subconfluent cells as compared to confluent cells, whereas cholesterol-alpha-epoxide is essentially equitoxic to confluent and subconfluent cells. Cholesterol epoxide cytotoxicity is significantly reduced by treatments in the absence of serum in accord with substantial reduction in uptake when incubations are performed in serum- free media. Our findings show that these cytotoxic cholesterol oxides are incorporated by endothelial cells through a combination of receptor- mediated and nonspecific or passive mechanisms; however, the efficacy of uptake and resulting toxicity is substantially influenced by serum lipoproteins.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. K. Pulfer, C. Taube, E. Gelfand, and R. C. Murphy Ozone Exposure in Vivo and Formation of Biologically Active Oxysterols in the Lung J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 256 - 264. [Abstract] [Full Text] [PDF]

				M. K. Pulfer and R. C. Murphy Formation of Biologically Active Oxysterols during Ozonolysis of Cholesterol Present in Lung Surfactant J. Biol. Chem., June 18, 2004; 279(25): 26331 - 26338. [Abstract] [Full Text] [PDF]

				C. Brandsch, R. Ringseis, and K. Eder High Dietary Iron Concentrations Enhance the Formation of Cholesterol Oxidation Products in the Liver of Adult Rats Fed Salmon Oil with Minimal Effects on Antioxidant Status J. Nutr., August 1, 2002; 132(8): 2263 - 2269. [Abstract] [Full Text] [PDF]

				H. N. Hodis, S. Hashimoto, W. J. Mack, and A. Sevanian Probucol Reduces Oxysterol Formation in Hypertensive Rabbits Hypertension, September 1, 2000; 36(3): 436 - 441. [Abstract] [Full Text] [PDF]

				G. J. Schroepfer Jr. Oxysterols: Modulators of Cholesterol Metabolism and Other Processes Physiol Rev, January 1, 2000; 80(1): 361 - 554. [Abstract] [Full Text] [PDF]

				J. X. Rong, L. Shen, Y. H. Chang, A. Richters, H. N. Hodis, and A. Sevanian Cholesterol Oxidation Products Induce Vascular Foam Cell Lesion Formation in Hypercholesterolemic New Zealand White Rabbits Arterioscler. Thromb. Vasc. Biol., September 1, 1999; 19(9): 2179 - 2188. [Abstract] [Full Text] [PDF]

				M. Moreau, I. Brocheriou, L. Petit, E. Ninio, M. J. Chapman, and M. Rouis Interleukin-8 Mediates Downregulation of Tissue Inhibitor of Metalloproteinase-1 Expression in Cholesterol-Loaded Human Macrophages : Relevance to Stability of Atherosclerotic Plaque Circulation, January 26, 1999; 99(3): 420 - 426. [Abstract] [Full Text] [PDF]

				J. X. Rong, S. Rangaswamy, L. Shen, R. Dave, Y. H. Chang, H. Peterson, H. N. Hodis, G. M. Chisolm, and A. Sevanian Arterial Injury by Cholesterol Oxidation Products Causes Endothelial Dysfunction and Arterial Wall Cholesterol Accumulation Arterioscler. Thromb. Vasc. Biol., December 1, 1998; 18(12): 1885 - 1894. [Abstract] [Full Text] [PDF]

				V. Deckert, L. Persegol, L. Viens, G. Lizard, A. Athias, C. Lallemant, P. Gambert, and L. Lagrost Inhibitors of Arterial Relaxation Among Components of Human Oxidized Low-Density Lipoproteins: Cholesterol Derivatives Oxidized in Position 7 Are Potent Inhibitors of Endothelium-Dependent Relaxation Circulation, February 4, 1997; 95(3): 723 - 731. [Abstract] [Full Text]

				A. Stiko, J. Regnstrom, P. K. Shah, B. Cercek, and J. Nilsson Active Oxygen Species and Lysophosphatidylcholine Are Involved in Oxidized Low Density Lipoprotein Activation of Smooth Muscle Cell DNA Synthesis Arterioscler. Thromb. Vasc. Biol., February 1, 1996; 16(2): 194 - 200. [Abstract] [Full Text]